NCT05711823 2024-01-23
Aprepitant Plus Granisetron and Dexamethasone for the Prevention of Vomiting in Patients With HAIC Therapy for HCC
Guangxi Medical University
Phase 3 Unknown
Clinical Trials
63 trialsNCT05910970 2024-01-23
PREVENT-2
Guangxi Medical University
Phase 3 Unknown
NCT05263219 2023-06-22
DEB-TACE+HAIC vs. HAIC for Large HCC
Second Affiliated Hospital of Guangzhou Medical University
Phase 3 Unknown
NCT05866172 2023-05-19
HAIC Combined Withzoledronic Acid for the Prevention of Bone Metastases in Advanced HCC
Sun Yat-sen University
Phase 3 Unknown
NCT02125396 2023-01-27
ARTC-HCC
Guangxi Medical University
Phase 3 Unknown
NCT04720716 2022-09-19
A Study to Compare the Effectiveness and Safety of IBI310 Combined With Sintilimab Versus Sorafenib in the First-line Treatment of Advanced HCC
Innovent Biologics (Suzhou) Co. Ltd.
Phase 3 Unknown
NCT05472896 2022-07-25
TACE With Dicycloplatin(TP21) in Unresectable HCC
Zhongda Hospital
Phase 3 Unknown
NCT05231382 2022-05-24
Hepatic Arterial Infusion of Raltetrexed With Oxaliplatin(SALOX) Versus FOLFOX in Advanced Hepatocellular Carcinoma
Sun Yat-sen University
Phase 3 Unknown
NCT05220020 2022-05-19
TACE Combined With Lenvatinib Versus TACE Sequential Lenvatinib in the Treatment of Intermediate/Advanced Liver Cancer
Sun Yat-sen University
Phase 3 Unknown
NCT02192671 2022-01-18
HR-HCC/PHT
Guangxi Medical University
Phase 3 Unknown
NCT03338647 2021-12-02
SBRT or TACE for Advanced HCC
University of Aarhus
Phase 3 Unknown
NCT05056337 2021-09-24
Toripalimab in Combination With Lenvatinib and TACE for Conversion Therapy in Patients With Potentially Resectable HCC
Shanghai Zhongshan Hospital
Phase 3 Unknown
NCT04803019 2021-03-19
RAD-18-TAcE
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phase 3 Unknown
NCT04665609 2021-03-04
Thermal Ablation Combined With Anlotinib and TQB2450 Solution for HCC
Chinese PLA General Hospital
Phase 3 Unknown
NCT04229355 2021-02-09
DEB-TACE Plus Lenvatinib or Sorafenib or PD-1 Inhibitor for Unresectable Hepatocellular Carcinoma
Guangxi Medical University
Phase 3 Unknown
NCT04687163 2021-01-13
Sorafenib or Lenvatinib Plus HAIC of 130 mg/m² Oxaliplatin, and 5-fu vs Sorafenib or Lenvatinib Plus HAIC of 85mg/m² Oxaliplatin, and 5-fu for Unresectable Advanced HCC: a Randomised Phase 3 Trial
Sun Yat-sen University
Phase 3 Unknown
NCT04667351 2020-12-14
HAIC of Oxaliplatin, and 2400 mg/m² 5-fu vs HAIC of Oxaliplatin, and 1200 mg/m² 5-fu for Unresectable HCC: a Randomised Phase 3 Non-inferiority Trial
Sun Yat-sen University
Phase 3 Unknown
NCT03898921 2020-11-24
RFA vs. SBRT for Small HCC
Sun Yat-sen University
Phase 3 Unknown
NCT02169765 2020-07-22
ARTC-HCC
Guangxi Medical University
Phase 3 Unknown
NCT03974074 2020-07-22
Albumin for Hepatocellular Carcinoma
Guangxi Medical University
Phase 3 Unknown
NCT02971345 2020-06-11
Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus
Shanghai Zhongshan Hospital
Phase 3 Unknown
NCT04392700 2020-05-19
A RCT of TNF and ENT in the Treatment of Long-term Prognosis With Hepatitis B-related HCC After Curative Resection
Sun Yat-sen University
Phase 3 Unknown
NCT03116984 2020-04-10
TACE-EBRT
Shanghai Zhongshan Hospital
Phase 3 Unknown
NCT04237740 2020-03-24
RRHCCLT
RenJi Hospital
Phase 3 Unknown
NCT02436902 2020-01-10
A-TACE/S-HCC
Guangxi Medical University
Phase 3 Unknown
NCT04202523 2019-12-17
Combined Radiotherapy and Radiofrequency Ablation for Hepatocellular Carcinoma
Guangxi Medical University
Phase 3 Unknown
NCT03851913 2019-11-29
The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Beyond Milan Criteria BCLC Stage A/B Hepatocellular Carcinoma Who Underwent Hepatectomy
Sun Yat-sen University
Phase 3 Unknown
NCT04006275 2019-09-19
Comparing SonoVue With Sonazoid Using CEUS-LIRADS in HCC
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 3 Unknown
NCT04053972 2019-08-13
The Impact on Recurrence Risk of Adjuvant Lenvatinib for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.
Sun Yat-sen University
Phase 3 Unknown
NCT04053985 2019-08-13
The Efficacy of Transarterial Chemoinfusion (TAI) Combine Lenvatinib in Advanced Hepatocellular Carcinoma (HCC)
Sun Yat-sen University
Phase 3 Unknown
NCT01936233 2019-08-05
Clinical Study of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery
Fudan University
Phase 3 Unknown
NCT03939845 2019-05-07
A Prospective, Randomized, Multicenter Study of Comparison of TACE Combination With and Without EBRT for Hepatocellular Carcinoma With Portal Vein Tumor Thrombi
Shanghai Zhongshan Hospital
Phase 3 Unknown
NCT02232490 2019-02-26
Hepko-V5
Immunitor LLC
Phase 3 Unknown
NCT03775395 2019-01-03
HAIC Plus Lenvatinib vs HAIC Plus Sorafenib for Advanced HCC
Sun Yat-sen University
Phase 3 Unknown
NCT03469479 2018-08-02
Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria
Sun Yat-sen University
Phase 3 Unknown
NCT03551444 2018-06-11
CAUTIOUS
Ain Shams University
Phase 3 Unknown
NCT01681446 2018-06-01
Adjuvant IFN-α for Patients Underwent Curative Surgery for HCC With a Low miR-26 Expression
Fudan University
Phase 3 Unknown
NCT03516448 2018-05-04
Expanding Phase III Study of Tyroserleutide for Injection
Shenzhen Kangzhe Pharmaceutical Co., Ltd.
Phase 3 Unknown
NCT01135056 2018-04-24
SIRveNIB
Singapore General Hospital
Phase 3 Unknown
NCT03468231 2018-03-16
HAIC of FOLFOX vs. HAIC of OXA for Advanced HCC
Sun Yat-sen University
Phase 3 Unknown
NCT03192618 2017-06-20
The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.
Sun Yat-sen University
Phase 3 Unknown
NCT03192644 2017-06-20
The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.
Sun Yat-sen University
Phase 3 Unknown
NCT01869088 2017-03-16
TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma
Sun Yat-sen University
Phase 3 Unknown
NCT01966133 2017-01-09
TACE as an Adjuvant Therapy After Hepatectomy for HCC
Fudan University
Phase 3 Unknown
NCT02738697 2016-11-02
Adjuvant Chemotherapy With FOLFOX in HCC Patients After Resection
Sun Yat-sen University
Phase 3 Unknown
NCT02630108 2016-10-18
TACE Combined With Synchronous Radiofrequency /Microwave Ablation to Treat Large and Huge Hepatocellular Carcinoma
Shanghai Zhongshan Hospital
Phase 3 Unknown
NCT02771405 2016-05-13
FRI-STC
National Hepatology & Tropical Medicine Research Institute
Phase 3 Unknown
NCT02755311 2016-04-28
Liver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular Carcinoma
Sun Yat-sen University
Phase 3 Unknown
NCT02301091 2016-04-14
CORTT
Sun Yat-sen University
Phase 3 Unknown
NCT02338297 2016-04-01
Therapeutic Effect of Ethanol-gelfoam Mixture for the Treatment of Arterioportal Shunts (APS) in Patients With HCC
Nanjing Medical University
Phase 3 Unknown